Involvement of Reactive Oxygen Species in Membrane Phospholipid Breakdown and Energy Perturbation After Traumatic Brain Injury in the Rat

1998 ◽  
Vol 15 (7) ◽  
pp. 521-530 ◽  
Author(s):  
ANDERS LEWÉN ◽  
LARS HILLERED
2001 ◽  
Vol 21 (11) ◽  
pp. 1259-1267 ◽  
Author(s):  
Niklas Marklund ◽  
Tommy Lewander ◽  
Fredrik Clausen ◽  
Lars Hillered

In previous studies, the authors showed that the nitrone radical scavenger α-phenyl-N- tert-butyl nitrone (PBN) and its sulfo-derivative, 2-sulfo-phenyl-N- tert-butyl nitrone (S-PBN), attenuated cognitive disturbance and reduced tissue damage after traumatic brain injury (TBI) in rats. In the current study, the production of reactive oxygen species (ROS) after TBI was monitored with microdialysis and the 4-hydroxybenzoic acid (4-HBA) trapping method. A single dose of PBN (30 mg/kg) or an equimolar dose of S-PBN (47 mg/kg) was administered intravenously 30 minutes before a controlled cortical contusion injury in rats. Plasma and brain tissue drug concentrations were analyzed at the end of the microdialysis experiment (3 hours after injury) and, in a separate experiment with S-PBN, at 30 and 60 minutes after injury. Traumatic brain injury caused a significant increase in ROS formation that lasted for 60 minutes after the injury as evidenced by increased 3,4-dihydroxybenzoic acid (3,4-DHBA) concentrations in the dialysate. PBN and S-PBN equally and significantly attenuated the posttraumatic increase in 3,4-DHBA formation. High PBN concentrations were found bilaterally in brain tissue up to 3 hours after injury. In contrast, S-PBN was rapidly cleared from the circulation and was not detectable in brain at 30 minutes after injury or at any later time point. The results suggest that scavenging of ROS after TBI may contribute to the neuroprotective properties observed with nitrone spin-trapping agents. S-PBN, which remained undetectable even in traumatized brain tissue, reduced ROS production to the same extent as PBN that readily crossed the blood–brain barrier. This finding supports an important role for ROS production at the blood–endothelial interface in TBI.


2020 ◽  
Vol 25 (45) ◽  
pp. 4737-4746
Author(s):  
Nicolas Toro-Urrego ◽  
Liliana F. Turner ◽  
Marco F. Avila-Rodriguez

: Traumatic Brain Injury is considered one of the most prevalent causes of death around the world; more than seventy millions of individuals sustain the condition per year. The consequences of traumatic brain injury on brain tissue are complex and multifactorial, hence, the current palliative treatments are limited to improve patients’ quality of life. The subsequent hemorrhage caused by trauma and the ongoing oxidative process generated by biochemical disturbances in the in the brain tissue may increase iron levels and reactive oxygen species. The relationship between oxidative damage and the traumatic brain injury is well known, for that reason, diminishing factors that potentiate the production of reactive oxygen species have a promissory therapeutic use. Iron chelators are molecules capable of scavenging the oxidative damage from the brain tissue and are currently in use for ironoverload- derived diseases. : Here, we show an updated overview of the underlying mechanisms of the oxidative damage after traumatic brain injury. Later, we introduced the potential use of iron chelators as neuroprotective compounds for traumatic brain injury, highlighting the action mechanisms of iron chelators and their current clinical applications.


PLoS ONE ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. e61819 ◽  
Author(s):  
Morgan A. Clond ◽  
Bong-Seop Lee ◽  
Jeffrey J. Yu ◽  
Matthew B. Singer ◽  
Takayuki Amano ◽  
...  

2012 ◽  
Vol 173 (2) ◽  
pp. e73-e81 ◽  
Author(s):  
Brett E. Larson ◽  
David W. Stockwell ◽  
Stefan Boas ◽  
Trevor Andrews ◽  
George C. Wellman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document